Cargando…
N-Acetylcysteine, an ROS Inhibitor, Alleviates the Pathophysiology of Hyperthyroidism-Induced Cardiomyopathy via the ROS/Ca(2+) Pathway
Hyperthyroidism is common and can induce cardiomyopathy, but there is no effective therapeutic strategy. The purpose of this study was to investigate the molecular mechanism of hyperthyroidism-induced cardiomyopathy (HTC) and the effect of N-acetylcysteine (NAC), an ROS inhibitor, on the pathophysio...
Autores principales: | Bao, Mengni, Hua, Xiumeng, Mo, Han, Sun, Zhe, Xu, Bo, Chen, Xiao, Xu, Mengda, Xu, Xinjie, Song, Jiangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496499/ https://www.ncbi.nlm.nih.gov/pubmed/36139036 http://dx.doi.org/10.3390/biom12091195 |
Ejemplares similares
-
Changes of Plasma Tris(hydroxymethyl)aminomethane and 5-Guanidino-3-methyl-2-oxopentanoic Acid as Biomarkers of Heart Remodeling after Left Ventricular Assist Device Support
por: Xu, Mengda, et al.
Publicado: (2022) -
Crosstalk between Calcium and ROS in Pathophysiological Conditions
por: Feno, Simona, et al.
Publicado: (2019) -
Inhibition of NETosis via PAD4 alleviated inflammation in giant cell myocarditis
por: Hu, Zhan, et al.
Publicado: (2023) -
Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
por: Kaludercic, Nina, et al.
Publicado: (2020) -
Subcellular Reactive Oxygen Species (ROS) in Cardiovascular Pathophysiology
por: Aldosari, Sarah, et al.
Publicado: (2018)